退黑素生理功能研究进展

doi:10.14088/j.cnki.issn0439-8114.2018.02.002

摘要/Abstract

摘要： 退黑素（Melatonin）是由松果体分泌的一种吲哚类激素。研究表明,退黑素具有改善睡眠、抗氧化、抗衰老、改善神经退行性疾病、镇痛、维持口腔健康等多种生理功能。对退黑素的生理功能研究进展进行了综述。

Abstract: Melatonin is a kind of indole hormone secreted by the pineal gland. Studies showed that melatonin exhibits many biological functions, such as improving sleep efficiency, anti-oxidation, anti-aging, ameliorating neurodegenerative diseases, easing pain, maintaining oral health, and the research advances on the functions were summarized.

Key words: melatonin, biological functions, sleep, anti-oxidation

中图分类号:

Q576

隋勇, 施建斌, 蔡沙, 何建军, 陈学玲, 梅新. 退黑素生理功能研究进展[J]. 湖北农业科学, 2018, 57(2): 9-13.

SUI Yong, SHI Jian-bin, CAI Sha, HE Jian-jun, CHEN Xue-ling, MEI Xin. Research Advances on the Biological Functions of Melatonin[J]. HUBEI AGRICULTURAL SCIENCES, 2018, 57(2): 9-13.

参考文献

[1] BRZEZINSKI A.Melatonin in humans[J].New England Journal of Medicine,1997,336(3):186-195.
[2] 赵瑛,刘志民,周晖.松果体及褪黑素[M].上海:上海科学技术文献出版社,2004.5-8.
[3] MANCHESTER L C,TAN D-X,REITER R J,et al.High levels of melatonin in the seeds of edible plants[J].Life Sciences,2000, 67(25):3023-3029.
[4] ARNAO M B,HERN NDEZ-RUIZ J. Growth conditions determine different melatonin levels in Lupinus albus L[J].Journal of Pineal Research,2013,55(2):149-155.
[5] 赵燕,王东华,赵曦阳.植物中褪黑素的研究进展[J].西北植物学报,2014,34(1):196-205.
[6] 王蒙,冯晓元,戴莹,等.樱桃果实褪黑素及其营养功能研究进展[J].食品科学,2014,35(19):307-311.
[7] ARNAO M B,HERN NDEZ-RUIZ J. Melatonin in plants[J].Plant Signaling & Behavior,2007,2(5):381-382.
[8] 郑建仙. 功能性食品(第二卷)[M].北京:中国轻工业出版社,1999.517-551.
[9] AULD F,MASCHAUER E L,MORRISON I,et al.Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders[J].Sleep Medicine Reviews,2017,34:10-22.
[10] 梁竹,魏玮,陶利.褪黑素在治疗睡眠障碍中的研究进展[J].解放军药学学报,2014,30(1):82-85.
[11] 何荆贵,王鲁宁,张宝和,等.褪黑素对老年原发性失眠患者的干预效应[J].中国临床康复,2005,9(12):73-75.
[12] SCHAEFER C,KUNZ D,BES F.Melatonin effects in REM sleep behavior disorder associated with obstructive sleep apnea syndrome:A case series[J].Current Alzheimer Research,2017, 14.
[13] RONDANELLI M,OPIZZI A,MONTEFERRARIO F,et al.The effect of melatonin,magnesium,and zinc on primary insomnia in long-term care facility residents in Italy: A double-blind,placebo-controlled clinical trial[J].Journal of the American Geriatrics Society,2011,59(1):82-90.
[14] LEMOINE P,NIR T,LAUDON M,et al.Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects[J].Journal of Sleep Research,2007,16(4):372-380.
[15] ZHONG G,NAISMITH S L,ROGERS N L,et al.Sleep-wake disturbances in common neurodegenerative diseases:A closer look at selected aspects of the neural circuitry[J].Journal of the Neurological Sciences,2011,307(1):9-14.
[16] PETER-DEREX L,YAMMINE P,BASTUJI H,et al.Sleep and Alzheimer's disease[J].Sleep Medicine Reviews,2015,19:29-38.
[17] WIENECKE M,WERTH E,PORYAZOVA R,et al.Progressive dopamine and hypocretin deficiencies in Parkinson's disease:is there an impact on sleep and wakefulness[J].Journal of Sleep Research,2012,21(6):710-717.
[18] ZHANG W,CHEN X-Y,SU S-W,et al.Exogenous melatonin for sleep disorders in neurodegenerative diseases:A meta-analysis of randomized clinical trials[J].Neurological Sciences,2016, 37(1):57-65.
[19] CARDINALI D P,FURIO A M,BRUSCO L I.Clinical aspects of melatonin intervention in Alzheimer's disease progression[J].Current Neuropharmacology,2010,8(3):218-227.
[20] VEATCH O J,PENDERGAST J S,ALLEN M J,et al.Genetic variation in melatonin pathway enzymes in children with autism spectrum disorder and comorbid sleep onset delay[J].Journal of Autism and Developmental Disorders,2015,45(1):100-110.
[21] WON J,JIN Y,CHOI J,et al.Melatonin as a novel interventional candidate for fragile X syndrome with autism spectrum disorder in humans[J].International Journal of Molecular Sciences,2017,18(6):1-15.
[22] AYYASH H F,PREECE P,MORTON R,et al.Melatonin for sleep disturbance in children with neurodevelopmental disorders:Prospective observational naturalistic study[J].Expert Review of Neurotherapeutics,2015,15(6):711-717.
[23] APEL K,HIRT H.Reactive oxygen species:metabolism,oxidative stress,and signal transduction[J].Annual Review of Plant Biology,2004,55:373-399.
[24] VALKO M,LEIBFRITZ D,MONCOL J,et al.Free radicals and antioxidants in normal physiological functions and human disease[J].International Journal of Biochemistry & Cell Biology,2007,39(1):44-84.
[25] REITER R J,TAN D-X,MANCHESTER L C,et al.Biochemical reactivity of melatonin with reactive oxygen and nitrogen species:A review of the evidence[J].Cell Biochemistry and Biophysics,2001,34(2):237-256.
[26] ACUNA CASTROVIEJO D,LOPEZ L C,ESCAMES G,et al.Melatonin-mitochondria interplay in health and disease[J].Current Topics in Medicinal Chemistry,2011,11(2):221-240.
[27] LOPEZ-BURILLO S,TAN D-X,MAYO J C,et al.Melatonin, xanthurenic acid,resveratrol,EGCG,vitamin C and α-lipoic acid differentially reduce oxidative DNA damage induced by Fenton reagents:A study of their individual and synergistic actions[J].Journal of Pineal Research,2003,34(4):269-277.
[28] KHALDY H,ESCAMES G,LE N J,et al.Comparative effects of melatonin,l-deprenyl, Trolox and ascorbate in the suppression of hydroxyl radical formation during dopamine autoxidation in vitro[J].Journal of Pineal Research,2000,29(2):100-107.
[29] MEHRZADI S,SAFA M,KAMRAVA S K,et al.Protective mechanisms of melatonin against hydrogen-peroxide-induced toxicity in human bone-marrow-derived mesenchymal stem cells[J].Canadian Journal of Physiology and Pharmacology,2016, 95(7):773-786.
[30] ESPINO J,PARIENTE J A,RODRIGUEZ A B.Oxidative stress and immunosenescence:Herapeutic effects of melatonin[J].Oxidative Medicine and Cellular Longevity,2012(4):1-9.
[31] TAMURA H,KAWAMOTO M,SATO S,et al.Long-term melatonin treatment delays ovarian aging[J].Journal of Pineal Research,2017,62(2):1-14.
[32] SRINIVASAN V,PANDI-PERUMAL S R,MAESTRONI G J M,et al. Role of melatonin in neurodegenerative diseases[J].Neurotoxicity Research,2005,7(4):293-318.
[33] KARASEK M.Melatonin,human aging,and age-related diseases[J].Experimental Gerontology,2004,39(11-12):1723-1729.
[34] XU J,RONG S,XIE B,et al.Changes in the nitric oxide system contribute to effect of procyanidins extracted from the lotus seedpod ameliorating memory impairment in cognitively impaired aged rats[J].Rejuvenation Research,2011,14(1):33-43.
[35] 许继取. 莲房原花青素对老年认知障碍大鼠记忆功能的改善作用及其机制研究[D].武汉:华中科技大学,2010.
[36] SWERDLOW R H,BURNS J M,KHAN S M.The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives[J].Biochimica Et Biophysica Acta-Molecular Basis of Disease,2014,1842(8):1219-1231.
[37] 凌志群,王小川,张少华,等.褪黑素对异丙肾上腺素诱导的大鼠海马tau蛋白过度磷酸化和空间记忆损伤的保护作用[J].中国病理生理杂志,2004,20(1):6-11.
[38] LIN H-W,LEE E J.Effects of melatonin in experimental stroke models in acute,sub-acute,and chronic stages[J].Neuropsychiatric Disease and Treatment,2009,5:157-162.
[39] HE H,DONG W,HUANG F.Anti-amyloidogenic and anti-apoptotic role of melatonin in Alzheimer disease[J].Current neuropharmacology,2010,8(3):211-217.
[40] GIBSON G E,STARKOV A,BLASS J P,et al.Cause and consequence:Mitochondrial dysfunction initiates and propagates neuronal dysfunction,neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases[J].Biochimica Et Biophysica Acta-Molecular Basis of Disease,2010,1802(1):122-134.
[41] EIRA J,SILVA C S,SOUSA M M,et al.The cytoskeleton as a novel therapeutic target for old neurodegenerative disorders[J].Progress in Neurobiology,2016,141:61-82.
[42] BENITEZ-KING G,RAMIREZ-RODRIGUEZ G,ORTIZ L,et al.The neuronal cytoskeleton as a potential therapeutical target in neurodegenerative diseases and schizophrenia[J].Current Drug Targets-CNS and Neurological Disorders,2004,3(6):515-533.
[43] SPATARO R,BONO V,MARCHESE S,et al.Tracheostomy mechanical ventilation in patients with amyotrophic lateral sclerosis:Clinical features and survival analysis[J].Journal of the Neurological Sciences,2012,323(1-2):66-70.
[44] WEISHAUPT J H,BARTELS C,P LKING E,et al. Reduced oxidative damage in ALS by high-dose enteral melatonin treatment[J].Journal of Pineal Research,2006,41(4):313-323.
[45] ZHANG Y,COOK A,KIM J,et al.Melatonin inhibits the caspase-1/cytochrome c/caspase-3 cell death pathway,inhibits MT1 receptor loss and delays disease progression in a mouse model of amyotrophic lateral sclerosis[J].Neurobiology of Disease,2013,55:26-35.
[46] WILHELMSEN M,AMIRIAN I,REITER R J,et al.Analgesic effects of melatonin:a review of current evidence from experimental and clinical studies[J].Journal of Pineal Research,2011, 51(3):270-277.
[47] EL-SHENAWY S M,ABDEL-SALAM O M E,BAIUOMY A R,et al. Studies on the anti-inflammatory and anti-nociceptive effects of melatonin in the rat[J].Pharmacological Research,2002,46(3):235-243.
[48] SONG G H,LENG P H,GWEE K A,et al.Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances:A randomised,double blind,placebo controlled study[J].Gut,2005,54(10):1402-1407.
[49] STEFANI L C,MULLER S,TORRES I L S,et al. A phase II,randomized,double-blind,placebo controlled,dose-response trial of the melatonin effect on the pain threshold of healthy subjects[J].PLOS ONE,2013,8(10):e74107.
[50] ANDERSEN L.The analgesic effects of exogenous melatonin in humans[J].Danish Medical Journal,2016,63(10):1-15.
[51] CUTANDO A,ANEIROS-FERNANDEZ J,LOPEZ-VALVERDE A,et al.A new perspective in oral health:potential importance and actions of melatonin receptors MT1,MT2,MT3,and RZR/ROR in the oral cavity[J].Archives of Oral Biology,2011, 56(10):944-950.
[52] BLASIAK J,KASZNICKI J,DRZEWOSKI J,et al.Perspectives on the use of melatonin to reduce cytotoxic and genotoxic effects of methacrylate-based dental materials[J].Journal of Pineal Research,2011,51(2):157-162.
[53] 李吉国. 褪黑素对牙髓炎TLR4、NF-κB调节机制的相关研究[D].西安:第四军医大学,2015.
[54] 徐丽. 褪黑素抗小鼠胃癌作用及其膜受体机制研究[D].福州:福建医科大学,2012.
[55] ORDONEZ R,CARBAJO-PESCADOR S,PRIETO-DOMINGUEZ N,et al.Inhibition of matrix metalloproteinase-9 and nuclear factor kappa B contribute to melatonin prevention of motility and invasiveness in HepG2 liver cancer cells[J].Journal of Pineal Research,2014,56(1):20-30.
[56] CHANG W-P,LIN C-C.Relationships of salivary cortisol and melatonin rhythms to sleep quality,emotion,and fatigue levels in patients with newly diagnosed lung cancer[J].European Journal of Oncology Nursing,2017,29:79-84.
[57] ITANI N,SKEFFINGTON K L,BECK C,et al.Melatonin rescues cardiovascular dysfunction during hypoxic development in the chick embryo[J].Journal of Pineal Research,2016,60(1):16-26.
[58] SUN H,GUSDON A M,QU S.Effects of melatonin on cardiovascular diseases:progress in the past year[J].Current Opinion in Lipidology,2016,27(4):408-413.
[59] RASTMANESH R.Potential of melatonin to treat or prevent age-related macular degeneration through stimulation of telomerase activity[J].Medical Hypotheses,2011,76(1):79-85.
[60] SALIDO E M,BORDONE M,DE LAURENTIIS A,et al.Therapeutic efficacy of melatonin in reducing retinal damage in an experimental model of early type 2 diabetes in rats[J].Journal of Pineal Research,2013,54(2):179-189.
[61] GARFINKEL D,ZORIN M,WAINSTEIN J,et al.Efficacy and safety of prolonged-release melatonin in insomnia patients with diabetes:A randomized,double-blind,crossover study[J].Diabetes,Metabolic Syndrome and Obesity:Targets and Therapy,2011(4):307-313.